Catalyst Wire Dossier Catalyst Wire Dossier

GOMEKLI

MIRDAMETINIB · SpringWorks Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GOMEKLI, covering 2025-02-11 to 2025-02-11. Get the full timeline:

Most recent: FDA Approved: GOMEKLI — Original Application (SpringWorks Therapeutics, Inc.)

See pricing